Ongoing, recruitingTherapeutic exploratory (Phase II)Interventional

An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.

At a glance

Status

Ongoing, recruiting

Phase

Therapeutic exploratory (Phase II)

Sponsor

Bioprojet Pharma

Enrolment target

Start

14 Aug 2023

Change from baseline of the Social Responsiveness Scale Second Edition (SRS-2) total score to the end of treatment period.

Age any to any · Sex: All

Always speak to your GP or specialist before deciding to take part in a study.